Verve Therapeutics, Inc.

Ownership Transactions Reported by 34 Insiders

Symbol
VERV on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 Brookline Avenue, Suite 601, Boston, Massachusetts

Insiders trading volume in the past year

Verve Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Krishna Yeshwant Director, More than 10% owner $122M +$18M +17.4% Dec 1, 2023
Gv 2017 Gp, L.L.C. Member of 10% Group $104M Nov 4, 2022
Gv 2019 Gp, L.L.C. More than 10% owner $44.7M Jun 21, 2021
ARCH Venture Partners X, LLC More than 10% owner $25.1M Jun 21, 2021
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. More than 10% owner $25M Jun 21, 2021
Casdin Partners Master Fund, L.P. More than 10% owner $24.2M Jun 21, 2021
Redmile Group, LLC More than 10% owner $19.4M Jun 21, 2021
Gv 2023 Gp, L.L.C. Member of 10% Group $18M Dec 1, 2023
Cormorant Asset Management, LP Former 10% Owner $9.84M Jun 21, 2021
Logos Global Management LP More than 10% owner $8.13M Jun 21, 2021
Broad Institute, Inc. More than 10% owner $8.1M Jun 21, 2021
Holdings A/S Novo More than 10% owner $7.93M Jun 21, 2021
Casdin Private Growth Equity Fund, L.P. More than 10% owner $6.21M Jun 21, 2021
Fmr Llc Other* $5.71M Jul 26, 2022
Beam Therapeutics Inc. More than 10% owner $5.47M Jun 21, 2021
Burt Adelman Director $4.28M Dec 31, 2023
Israel Rozen More than 10% owner $4.1M Jun 16, 2021
Barry Ticho More than 10% owner $4.1M Jun 16, 2021
Jae Keith Joung More than 10% owner $4.1M Jun 16, 2021
Andrew Ashe President, Chief Operating Officer $2.5M +$476K +23.5% May 14, 2024
Rock Springs Capital Management LP More than 10% owner $1.53M Jun 21, 2021
Sekar Kathiresan Chief Executive Officer, Director $1.32M Feb 14, 2024
Allison Dorval Chief Financial Officer $491K -$6.34K -1.28% Feb 14, 2024
Andrew Bellinger Chief Scientific Officer $450K Feb 14, 2024
Fred T. Fiedorek Chief Medical Officer $220K Feb 14, 2024
Joan Nickerson Chief Administrative Officer $171K -$12.5K -6.81% Apr 1, 2024
Margaret Beaudoin Vice President, Finance $10K Jun 17, 2021
Biomatics Capital Partners, L.P. More than 10% owner Jun 16, 2021
Sheila Mikhail Director Jun 15, 2023
Lonnel Coats Director Jun 15, 2023
ARCH Venture Fund X, L.P. More than 10% owner Jun 16, 2021
Michael F. MacLean Director Jun 15, 2023
Alexander Cumbo Director Jun 15, 2023
John M. Evans Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for Verve Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership